
Arpad Fabian-kovacs
Examiner (ID: 16444)
Most Active Art Unit | 3671 |
Art Unit(s) | 3616, 3671 |
Total Applications | 3046 |
Issued Applications | 2528 |
Pending Applications | 99 |
Abandoned Applications | 392 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6167874
[patent_doc_number] => 20110196017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'MICRO-RNA THAT PROMOTES VASCULAR INTEGRITY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/058801
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 30184
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20110196017.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058801
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058801 | MICRO-RNA THAT PROMOTES VASCULAR INTEGRITY AND USES THEREOF | Aug 10, 2009 | Abandoned |
Array
(
[id] => 8199307
[patent_doc_number] => 20120122800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Long-Acting DNA Dendrimers and Methods Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/058123
[patent_app_country] => US
[patent_app_date] => 2009-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24115
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122800.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058123
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058123 | Long-Acting DNA Dendrimers and Methods Thereof | Aug 9, 2009 | Abandoned |
Array
(
[id] => 7490673
[patent_doc_number] => 20110237646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'MODULATION OF TRANSTHYRETIN EXPRESSION FOR THE TREATMENT OF CNS RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/056295
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20603
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237646.pdf
[firstpage_image] =>[orig_patent_app_number] => 13056295
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/056295 | MODULATION OF TRANSTHYRETIN EXPRESSION FOR THE TREATMENT OF CNS RELATED DISORDERS | Aug 6, 2009 | Abandoned |
Array
(
[id] => 9692065
[patent_doc_number] => 08822660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-02
[patent_title] => 'Cell death pre-mRNA-encoding DNA'
[patent_app_type] => utility
[patent_app_number] => 12/511510
[patent_app_country] => US
[patent_app_date] => 2009-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 97
[patent_no_of_words] => 24948
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12511510
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/511510 | Cell death pre-mRNA-encoding DNA | Jul 28, 2009 | Issued |
Array
(
[id] => 9060118
[patent_doc_number] => 08546553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Prokaryotic RNAi-like system and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/055769
[patent_app_country] => US
[patent_app_date] => 2009-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 23
[patent_no_of_words] => 28613
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055769
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055769 | Prokaryotic RNAi-like system and methods of use | Jul 23, 2009 | Issued |
Array
(
[id] => 6015783
[patent_doc_number] => 20110223665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND'
[patent_app_type] => utility
[patent_app_number] => 13/055894
[patent_app_country] => US
[patent_app_date] => 2009-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 48271
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223665.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055894
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055894 | ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND | Jul 23, 2009 | Abandoned |
Array
(
[id] => 7487946
[patent_doc_number] => 20110251258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'RNAI CONSTRUCTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/055617
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 34018
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251258.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055617
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055617 | RNAI CONSTRUCTS AND USES THEREOF | Jul 22, 2009 | Abandoned |
Array
(
[id] => 6483682
[patent_doc_number] => 20100008966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Medical Devices and Methods for Delivery of Nucleic Acids'
[patent_app_type] => utility
[patent_app_number] => 12/502473
[patent_app_country] => US
[patent_app_date] => 2009-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8979
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20100008966.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502473
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502473 | Medical Devices and Methods for Delivery of Nucleic Acids | Jul 13, 2009 | Abandoned |
Array
(
[id] => 6425508
[patent_doc_number] => 20100151458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA'
[patent_app_type] => utility
[patent_app_number] => 12/502050
[patent_app_country] => US
[patent_app_date] => 2009-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 32477
[patent_no_of_claims] => 116
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151458.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502050 | OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA | Jul 12, 2009 | Abandoned |
Array
(
[id] => 6091080
[patent_doc_number] => 20110218334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/003355
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 37503
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218334.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003355
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003355 | PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS | Jul 9, 2009 | Abandoned |
Array
(
[id] => 6001788
[patent_doc_number] => 20110117627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'REGULATION OF APOPTOSIS BY NEURAL SPECIFIC SPLICE VARIANTS OF IG20'
[patent_app_type] => utility
[patent_app_number] => 13/003215
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14475
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117627.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003215
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003215 | REGULATION OF APOPTOSIS BY NEURAL SPECIFIC SPLICE VARIANTS OF IG20 | Jul 9, 2009 | Abandoned |
Array
(
[id] => 6084410
[patent_doc_number] => 20110144185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'RNA ANTAGONISTS TARGETING HSP27'
[patent_app_type] => utility
[patent_app_number] => 13/000278
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 25427
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144185.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000278
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000278 | RNA antagonists targeting Hsp27 | Jun 30, 2009 | Issued |
Array
(
[id] => 9469008
[patent_doc_number] => 08722638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-13
[patent_title] => 'Methods for the modulation of angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 12/999746
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 64
[patent_no_of_words] => 58622
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999746
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999746 | Methods for the modulation of angiogenesis | Jun 18, 2009 | Issued |
Array
(
[id] => 6113922
[patent_doc_number] => 20110190375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'COMPOSITIONS COMPRISING CMYC SIRNA AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/996966
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25143
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190375.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996966 | COMPOSITIONS COMPRISING CMYC SIRNA AND METHODS OF USE THEREOF | Jun 10, 2009 | Abandoned |
Array
(
[id] => 6431008
[patent_doc_number] => 20100152095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'Wound healing'
[patent_app_type] => utility
[patent_app_number] => 12/457346
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5903
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152095.pdf
[firstpage_image] =>[orig_patent_app_number] => 12457346
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457346 | Wound healing | Jun 7, 2009 | Abandoned |
Array
(
[id] => 6229628
[patent_doc_number] => 20100184032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/478586
[patent_app_country] => US
[patent_app_date] => 2009-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 249
[patent_figures_cnt] => 249
[patent_no_of_words] => 73728
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184032.pdf
[firstpage_image] =>[orig_patent_app_number] => 12478586
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/478586 | Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof | Jun 3, 2009 | Abandoned |
Array
(
[id] => 6489180
[patent_doc_number] => 20100009451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/474395
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8064
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009451.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474395 | COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID | May 28, 2009 | Abandoned |
Array
(
[id] => 9020452
[patent_doc_number] => 08530437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Methods for treating cancer using herpes simplex virus expressing antisense to the squamous cell carcinoma related oncogene'
[patent_app_type] => utility
[patent_app_number] => 12/436382
[patent_app_country] => US
[patent_app_date] => 2009-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20183
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12436382
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/436382 | Methods for treating cancer using herpes simplex virus expressing antisense to the squamous cell carcinoma related oncogene | May 5, 2009 | Issued |
Array
(
[id] => 6375841
[patent_doc_number] => 20100076060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Aptamers as agonists'
[patent_app_type] => utility
[patent_app_number] => 12/385797
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8815
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076060.pdf
[firstpage_image] =>[orig_patent_app_number] => 12385797
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/385797 | Aptamers as agonists | Apr 19, 2009 | Abandoned |
Array
(
[id] => 8251822
[patent_doc_number] => 20120156138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming'
[patent_app_type] => utility
[patent_app_number] => 13/264482
[patent_app_country] => US
[patent_app_date] => 2009-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 68050
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20120156138.pdf
[firstpage_image] =>[orig_patent_app_number] => 13264482
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/264482 | Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming | Apr 13, 2009 | Abandoned |